MED logo

Medifast (MED)

Profile

Full Name

Medifast, Inc.

Ticker Symbol

MED

Exchange

NYSE

Sector

Consumer Cyclical

Industry

Personal Services

Country

United States

IPO

December 30, 1993

Indexes

Not included

Website

http://medifastinc.com

Employees

504

Key Details

Price

$11.65(-2.27%)

Market cap

$127.43M(Small cap)

Last Dividend

$1.65

TTM Dividend yield

-

Annual revenue

$602.46M(-43.80% YoY)

Annual EPS

$0.19(-97.91% YoY)

PE ratio

64.72

Next earnings date

Apr 28, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$11.65
MED price is $11.65

30-Day Relative Volume

0.94
MED 30-day relative volume is 0.94

Price Performance

Price Today change

-2.27%
MED price is down -2.27% today

Price YTD change

-33.88%
MED price is down -33.88% since January 1st

Price 1-year change

-64.09%
MED price is down -64.09% year-on-year

Price 3-year change

-93.76%
MED price is down -93.76% over the past 3 years

Price Range

Price All-time high

$336.99
MED price is currently -96.54% below its historical high of $336.99

Price 3-year low

$11.65
MED price is currently at its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$127.43M
MED market capitalization is $127.43 million

Market cap 3-year change

-94.08%
MED market capitalization is down -94.08% over the past 3 years

Market cap All-time high

$3.91B
MED market capitalization is currently -96.74% below its historical high of $3.91 billion

Market cap sector rank

32.43%
MED market capitalization is higher than 32.43% of companies in Consumer Cyclical sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.01%
MED shares outstanding is up +0.01% year-on-year

Shares Outstanding 3-Year Change

-5.32%
MED shares outstanding is down -5.32% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.36
MED beta is 0.36

200-day SMA

$17.34
MED price is currently -32.81% below its 200-day simple moving average

50-day SMA

$14.06
MED price is currently -17.13% below its 50-day simple moving average

RSI

32.66
MED 14-day relative strength index is 32.66

Volume

0.94
MED 30-day relative volume is 0.94

ATR

$0.58
MED average true range is $0.58

10-day Historical Volatility

41.92%
MED 10-day historical volatility is 41.92%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$1.65
MED last dividend was $1.65 per share, with an ex-dividend date of September 18, 2023

Next Dividend

-
MED next dividend has not yet been announced

Dividend per share

Dividend per share

-
MED annual dividend per share value is unknown

Dividend per share Sector Rank

-
MED annual dividend per share is unknown

Dividend per share 1-Year Change

-
MED annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
MED annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
MED annual dividend yield value is unknown

Dividend yield Sector Rank

-
MED annual dividend yield is unknown

Other

Payout ratio

34.19%
MED annual payout ratio is 34.19%

Dividends paid

$715.00K
MED annual dividends paid is $715.00 thousand

Free cash flow

$17.02M
MED annual free cash flow is $17.02 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$602.46M
MED annual revenue is $602.46 million

Revenue Analysts estimate

$406.10M
MED annual revenue is currently +48.35% higher than the consensus analysts' forecast

Revenue 1-year change

-43.8%
MED annual revenue is down -43.8% year-on-year

Revenue Sector rank

39.56%
MED annual revenue is higher than 39.56% of companies in Consumer Cyclical sector

EPS

EPS

$0.19
MED annual earnings per share is $0.19

EPS Analysts estimate

-$1.05
MED annual earnings per share is currently -118.10% lower than the consensus analysts' forecast

EPS 1-year change

-97.91%
MED annual earnings per share is down -97.91% year-on-year

EPS Sector rank

49.23%
MED annual earnings per share is higher than 49.23% of companies in Consumer Cyclical sector

Profit

Gross profit

$444.62M
MED annual gross profit is $444.62 million

Gross margin

73.80%
MED annual gross profit margin is 73.80%

Operating profit

$2.88M
MED annual operating income is $2.88 million

Operating margin

0.48%
MED annual operating profit margin is 0.48%

Net income

$2.09M
MED annual net profit is $2.09 million

Net margin

0.35%
MED annual net profit margin is 0.35%

Expenses

Total expenses

$599.59M
MED annual total expenses is $599.59 million

Operating expenses

$441.75M
MED annual total operating expenses is $441.75 million

Cost of goods sold

$157.84M
MED annual cost of goods sold is $157.84 million

Selling, general & administrative expenses

$441.75M
MED annual SGA is $441.75 million

Depreciation and amortization

$12.71M
MED annual depreciation & amortization is $12.71 million

Interest expense

-
MED annual interest expense value is unknown

Income tax

$1.70M
MED annual income tax is $1.70 million

EBIT & EBITDA

EBIT

$2.88M
MED annual earnings before interest & taxes is $2.88 million

EBITDA

$15.59M
MED annual EBITDA is $15.59 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$284.21M
MED annual total assets is $284.21 million

Non current assets

$69.81M
MED annual long term assets is $69.81 million

Current assets

$214.40M
MED annual total current assets is $214.40 million

Cash and cash equivalents

$90.93M
MED annual cash & cash equivalents is $90.93 million

Accounts receivable

-
MED annual accounts receivable value is unknown

Inventory

$42.42M
MED annual inventory is $42.42 million

Liabilities

Total liabilities

$74.10M
MED annual total liabilities is $74.10 million

Long term liabilities

$9.94M
MED annual total long term liabilities is $9.94 million

Current liabilities

$64.16M
MED annual total current liabilities is $64.16 million

Accounts payable

$23.05M
MED annual accounts payable is $23.05 million

Debt

Total debt

$16.13M
MED annual total debt is $16.13 million

Total debt 1-year change

-26.74%
MED annual total debt is down -26.74% year-on-year

Long term debt

$9.94M
MED annual long term debt is $9.94 million

Short term debt

$6.18M
MED annual short term debt is $6.18 million

Equity & Capital

Shareholders equity

$210.11M
MED annual stockholders equity is $210.11 million

Book value

$210.11M
MED annual book value is $210.11 million

Retained earnings

$176.78M
MED annual retained earnings is $176.78 million

Working capital

$150.24M
MED annual working capital is $150.24 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$24.48M
MED annual cash flow from operations is $24.48 million

Cash from operations 1-year change

-83.42%
MED annual cash flow from operations is down -83.42% year-on-year

Cash from investing

-$26.52M
MED annual cash flow from investing activities is -$26.52 million

Cash from investing 1-year change

+56.56%
MED annual cash flow from investing activities is up +56.56% year-on-year

Cash from financing

-$1.51M
MED annual cash flow from financing activities is -$1.51 million

Cash from financing 1-year change

+98.1%
MED annual cash flow from financing activities is up +98.1% year-on-year

CAPEX

CAPEX

$7.45M
MED annual capital expenditures is $7.45 million

CAPEX 1-year change

+14.98%
MED annual capital expenditures is up +14.98% year-on-year

Free Cash Flow

Free cash flow

$17.02M
MED annual free cash flow is $17.02 million

Free cash flow 1-year change

-87.94%
MED annual free cash flow is down -87.94% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

73.80%
MED annual gross profit margin is 73.80%

Operating margin

0.48%
MED annual operating profit margin is 0.48%

Net margin

0.35%
MED annual net profit margin is 0.35%

ROA & ROE

ROA

0.70%
MED annual return on assets is 0.70%

ROE

1.02%
MED annual return on equity is 1.02%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

64.72
MED price to earnings ratio is 64.72

PE ratio Sector rank

91.43%
MED price to earnings ratio is higher than 91.43% of companies in Consumer Cyclical sector

PB Ratio

PB ratio

0.61
MED price to book ratio is 0.61

PB ratio Sector rank

33.67%
MED price to book ratio is higher than 33.67% of companies in Consumer Cyclical sector

PS Ratio

PS ratio

0.21
MED price to sales ratio is 0.21

PS ratio Sector rank

21.62%
MED price to sales ratio is higher than 21.62% of companies in Consumer Cyclical sector

Enterprise value

Enterprise value

$52.62M
MED enterprise value is $52.62 million

Enterprise value Sector rank

17.46%
MED enterprise value is higher than 17.46% of companies in Consumer Cyclical sector

EV/EBITDA

EV/EBITDA

3.38
MED EV/EBITDA is 3.38

EV/EBITDA Sector rank

28.68%
MED EV/EBITDA is higher than 28.68% of companies in Consumer Cyclical sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.34
MED annual current ratio is 3.34

Quick ratio

2.68
MED annual quick ratio is 2.68

Leverage

Debt to equity

0.00
MED annual debt to equity ratio is 0.00

Interest coverage ratio

-
MED annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

7
MED piotroski f-score is 7

Altman Z-Score

4.69
MED altman z-score is 4.69

Analyst ratings

Recent major analysts updates

Feb 19, 25 DA Davidson
Neutral
Nov 5, 24 DA Davidson
Neutral
Jul 22, 24 DA Davidson
Underperform
Jun 5, 24 DA Davidson
Underperform
Apr 30, 24 DA Davidson
Neutral
Feb 21, 24 DA Davidson
Neutral
Oct 13, 23 Stephens & Co.
Equal-Weight
Aug 8, 23 DA Davidson
Neutral
Jul 31, 23 DA Davidson
Neutral
May 2, 23 DA Davidson
Neutral

Institutional Ownership

Similar stocks

BZUN logo
Baozun (BZUN)
AOUT logo
American Outdoor Brands (AOUT)
DBI logo
Designer Brands (DBI)
PLCE logo
Childrens Place (PLCE)
INVZ logo
Innoviz Technologies (INVZ)
WISH logo
ContextLogic (WISH)
CLAR logo
Clarus (CLAR)
United Homes (UHG)
Creative Global Technology Holdings Limited (CGTL)
  • What is the ticker symbol for Medifast?
  • Does Medifast pay dividends?
  • What sector is Medifast in?
  • What industry is Medifast in?
  • What country is Medifast based in?
  • When did Medifast go public?
  • Is Medifast in the S&P 500?
  • Is Medifast in the NASDAQ 100?
  • Is Medifast in the Dow Jones?
  • When was Medifast's last earnings report?
  • When does Medifast report earnings?
  • Should I buy Medifast stock now?

What is the ticker symbol for Medifast?

The ticker symbol for Medifast is NYSE:MED

Does Medifast pay dividends?

No, Medifast does not pay dividends

What sector is Medifast in?

Medifast is in the Consumer Cyclical sector

What industry is Medifast in?

Medifast is in the Personal Services industry

What country is Medifast based in?

Medifast is headquartered in United States

When did Medifast go public?

Medifast's initial public offering (IPO) was on December 30, 1993

Is Medifast in the S&P 500?

No, Medifast is not included in the S&P 500 index

Is Medifast in the NASDAQ 100?

No, Medifast is not included in the NASDAQ 100 index

Is Medifast in the Dow Jones?

No, Medifast is not included in the Dow Jones index

When was Medifast's last earnings report?

Medifast's most recent earnings report was on Feb 18, 2025

When does Medifast report earnings?

The next expected earnings date for Medifast is Apr 28, 2025

Should I buy Medifast stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page